Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Aroon D Hingorani Centre for
Clinical Pharmacology, Wolfson Institute for Biomedical Research,
University College London, London W1P 9LN
Correspondence to: Dr Hingorani
a.hingorani{at}ucl.ac.uk
Objective:
To describe, and to test against trial
data, a simple and flexible computer program for calculating
cardiovascular risk in individual patients as an aid to managing risk
factors and prescribing drugs to lower cholesterol concentration and
blood pressure.
Design:
Descriptive comparison of actual
cardiovascular risk in randomised controlled trials of cholesterol
reduction with risk predicted by a computer program based on the
Framingham risk equation. Comparison of the program's performance with
that of tables and guidelines by means of hypothetical case examples.
Main outcome measures:
Average risk of coronary heart
disease and myocardial infarction.
Results:
The computer program accurately
predicted baseline absolute risk in a UK population as well as the
relative and absolute reduction in risk from cholesterol lowering for
primary prevention of coronary heart disease. The program also allowed a more refined estimate of absolute risk of coronary heart disease than
some existing tables and enabled the impact of prescribing decisions to
be quantified and costed.
Conclusions:
This simple computer program to estimate
individuals' cardiovascular disease risk and display the benefits of
intervention should help clinicians and patients decide on the most
effective packages of risk reduction and identify those most likely to
benefit from modulation of risk factors.
Key messages
© BMJ 1999
Read all Rapid Responses